Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Structural Heart Highlights: Interventional echocardiography | Valve-in-valve TMVR | AI spots missed defects

News You Need to Know Today
Structural Heart Highlights: Interventional echocardiography | Valve-in-valve TMVR | AI spots missed defects
Monday, September 11, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Interventional echocardiography expected to grow thanks to new structural heart procedures

American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.

READ MORE >
Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.
Share on Twitter Share on Facebook Share on Linkedin

Interventional echocardiography expected to grow thanks to new structural heart procedures

Share on Twitter Share on Facebook Share on Linkedin
Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.
American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.
READ MORE >

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

READ MORE >
The depth of left atrial appendage occlusion (LAAO) devices inside the LAA impacts outcomes. #LAAO
Share on Twitter Share on Facebook Share on Linkedin

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Share on Twitter Share on Facebook Share on Linkedin
The depth of left atrial appendage occlusion (LAAO) devices inside the LAA impacts outcomes. #LAAO
Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.
READ MORE >

Cardiologists detail long-term outcomes of valve-in-valve TMVR

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

READ MORE >
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists detail long-term outcomes of valve-in-valve TMVR

Share on Twitter Share on Facebook Share on Linkedin
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.
READ MORE >

Interventional echocardiographers play a key role in the treatment of structural heart disease

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

READ MORE >
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Share on Twitter Share on Facebook Share on Linkedin

Interventional echocardiographers play a key role in the treatment of structural heart disease

Share on Twitter Share on Facebook Share on Linkedin
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.
READ MORE >

AI spots critical heart defects missed by the human eye

“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 

READ MORE >
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Share on Twitter Share on Facebook Share on Linkedin

AI spots critical heart defects missed by the human eye

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 
READ MORE >

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

READ MORE >
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific gains FDA approval for Watchman FLX Pro LAAC device

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Watchman FLX Pro left atrial appendage closure (LAAC) device
This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 
READ MORE >

How monitoring MR can help cardiologists anticipate TAVR outcomes in patients with low-flow, low-gradient AS

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.

READ MORE >
Mitral valve with regurgitation 3D ICE Siemens ICE at #ASE2023.
Share on Twitter Share on Facebook Share on Linkedin

How monitoring MR can help cardiologists anticipate TAVR outcomes in patients with low-flow, low-gradient AS

Share on Twitter Share on Facebook Share on Linkedin
Mitral valve with regurgitation 3D ICE Siemens ICE at #ASE2023.
Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup